Adipocyte-specific expression of a retinoic acid receptor α dominant negative form causes glucose intolerance and hepatic steatosis in mice

Biochem Biophys Res Commun. 2019 Jul 5;514(4):1231-1237. doi: 10.1016/j.bbrc.2019.05.075. Epub 2019 May 17.

Abstract

All-trans-retinoic acid (ATRA) has been well described as a positive regulator for early stage of adipocyte differentiation and lipid metabolism and also linked to an in vivo fat-lowering effect in mice. However, not all studies support this association. Our objective was to characterize the action of ATRA in mature adipocytes of mice by ablating RAR signaling through overexpression of a well-characterized dominant negative RARα mutant (RARdn) form specifically in adipocytes. Altered RAR signaling in adipocytes resulted in a significant decrease in ATRA levels in visceral and brown adipose tissues as well as liver tissue. This was linked to significant impairments in glucose clearance and elevated hepatic lipid accumulation for chow diet fed mice, indicating the development of metabolic disease, including hepatic steatosis. In addition, we found that adipose RARdn expression in mice fed a chow diet decreased thermogenesis. We conclude that altered RAR signaling and ATRA levels in adipocytes impacts glucose and lipid metabolism in mice.

Keywords: All-trans-retinoic acid (ATRA); Glucose intolerance; Heat production; Hepatic steatosis; Retinoic acid receptor (RAR) signaling.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Adipocytes / metabolism*
  • Animals
  • Fatty Liver / metabolism*
  • Glucose Intolerance / metabolism*
  • Mice
  • Mice, Transgenic
  • Retinoic Acid Receptor alpha / genetics*
  • Retinoic Acid Receptor alpha / metabolism
  • Signal Transduction

Substances

  • Retinoic Acid Receptor alpha